IMG
- Manufacturer
- Yein Trading & Global Co., Ltd | Han Kook Sin Yak Pharmaceutical Co., Ltd.
- Effective date
- 2013-02-26
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:34:42
Label at a glance#
ProductIMG
Active ingredientPHELLINUS LINTEUS MYCELIUM
Label structure8 sections
Label contents#
Full prescribing information#
phellinus linteus mycelium
INACTIVE INGREDIENT SECTION
Zinc gluconate 3% (14.34% as Zinc), Vitamin C 10% (100% as vitamin C), Lactose 41%, Cordyceps militaris extract powder (mycelium culture) 6%, Chaga mushroom extract powder (mycelium culture) 6%, Ganoderma lucidum extract powder (mycelium culture) 6%, Trametes versicolor extract powder (mycelium culture) 6%, Grifola frondosa (mycelium culture) 6%, Hydroxypropylmethyl-cellulose 4%, Cultured Wild ginseng root powder 3%, Carboxymethylcellulose calcium 2%, Magnesium stearate 1%
OTC - PURPOSE SECTION
antitumor effect
prophylactic effect
immunostimulating effect
synergistic effect
prophylactic effect
immunostimulating effect
synergistic effect
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
keep out of reach of the children
INDICATIONS & USAGE SECTION
1. ulterine hemorrhage and hysterorrhea, dysmenorrhea, intestinal hemorrhage, activation of five organs and stomach function, detoxication
2. reinforcement of immune function by administration in parallel with any chemical therapy after any excising operation form the patient with cancer in digestive system or liver
2. reinforcement of immune function by administration in parallel with any chemical therapy after any excising operation form the patient with cancer in digestive system or liver
WARNINGS SECTION
DOSAGE & ADMINISTRATION SECTION
- uterine hemorrhage and hysterorrhea, dysmenorrhea, intestinal hemorrhage, activation of five organs and stomach function, detoxication : as a phellinus linteus mycelia extracts, administer 550~1100mg 2 times per a day before having a meal by mouth
- reinforcement of immune function by administration in parallel with any chemical therapy after any excising operation for the patient with cancer in digestive system or liver : as a phellinus linteus mycelia extracts, administer 1100mg 3 times per a day after having a meal by mouth
- reinforcement of immune function by administration in parallel with any chemical therapy after any excising operation for the patient with cancer in digestive system or liver : as a phellinus linteus mycelia extracts, administer 1100mg 3 times per a day after having a meal by mouth
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Product Linked Resources#
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 0851802004426 | GTIN-13: 0851802004426 EAN-13: 0851802004426 GTIN-12: 851802004426 UPC-A: 851802004426 GTIN storage (14 digits): 00851802004426 | label.jpg |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| c5cd4727-ac49-4409-82b1-5bd8006c3ec7 | Product name | 1 | 20171122 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 53144-3001-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-0460-f424-e053-dadaa90a57ce | Drug Facts |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 53144-3001-1 | IMG | 60 in 1 BOTTLE | TABLET | 60 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 53144-3001 | IMG (PHELLINUS LINTEUS MYCELIUM) TABLET [YEIN TRADING & GLOBAL CO., LTD] | 1 | Legacy NDC, 1 package rows | 20130226_44b31b35-8176-4f5b-bcca-3b7c17eccd98.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| PHELLINUS LINTEUS MYCELIUM | ACTIVE INGREDIENT | 40K19XJV3C | 1 | |
| PHELLINUS LINTEUS MYCELIUM | ACTIVE MOIETY | 40K19XJV3C | 1 | |
| ASCORBIC ACID | INACTIVE INGREDIENT | PQ6CK8PD0R | 1 | |
| CARBOXYMETHYLCELLULOSE CALCIUM | INACTIVE INGREDIENT | UTY7PDF93L | 1 | |
| GRIFOLA FRONDOSA WHOLE | INACTIVE INGREDIENT | O238UC53ET | 1 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | 1 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 1 | |
| REISHI | INACTIVE INGREDIENT | TKD8LH0X2Z | 1 | |
| TRAMETES VERSICOLOR FRUITING BODY | INACTIVE INGREDIENT | 4C900477MT | 1 | |
| ZINC GLUCONATE | INACTIVE INGREDIENT | U6WSN5SQ1Z | 1 |
Products#
Every source-derived product name is available through these pages.
- IMG
- PHELLINUS LINTEUS MYCELIUM
- ZINC GLUCONATE
- ASCORBIC ACID
- LACTOSE
- REISHI
- TRAMETES VERSICOLOR FRUITING BODY
- GRIFOLA FRONDOSA WHOLE
- HYPROMELLOSES
- CARBOXYMETHYLCELLULOSE CALCIUM
- MAGNESIUM STEARATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 53144-3001 | 53144-3001-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| ZINC GLUCONATE | U6WSN5SQ1Z | IACT |
| ASCORBIC ACID | PQ6CK8PD0R | IACT |
| LACTOSE | J2B2A4N98G | IACT |
| REISHI | TKD8LH0X2Z | IACT |
| TRAMETES VERSICOLOR FRUITING BODY | 4C900477MT | IACT |
| GRIFOLA FRONDOSA WHOLE | O238UC53ET | IACT |
| HYPROMELLOSES | 3NXW29V3WO | IACT |
| CARBOXYMETHYLCELLULOSE CALCIUM | UTY7PDF93L | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| PHELLINUS LINTEUS MYCELIUM | 40K19XJV3C | ACTIB |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| ASCORBIC ACID | ASCORBIC ACID | PQ6CK8PD0R | TABLET / ORAL | 80 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | SYRUP / ORAL | 250 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 53 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET / ORAL | 1127 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE / ORAL | 256.4 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | POWDER / ORAL | 25 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, FILM COATED / ORAL | 582 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | SUPPOSITORY / VAGINAL | NA | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FOR SUSPENSION / ORAL | 131 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | GRANULE / ORAL | 629 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, CHEWABLE / ORAL | 11.8 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | POWDER / RESPIRATORY (INHALATION) | 90 mg | ||
| ASCORBIC ACID | ASCORBIC ACID | PQ6CK8PD0R | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 2 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | SOLUTION / ORAL | 1682 mg/15ml | ||
| ASCORBIC ACID | ASCORBIC ACID | PQ6CK8PD0R | CONCENTRATE / ORAL | 6 mg/1ml | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / RECTAL | 20 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE / RESPIRATORY (INHALATION) | 44.4 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, ORALLY DISINTEGRATING / ORAL | 187 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | POWDER / TOPICAL | 104 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | GEL / RECTAL | 348 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | POWDER, FOR SOLUTION / ORAL | NA | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CAPSULE / ORAL | 1488 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, CHEWABLE / ORAL | 1412 mg | ||
| ASCORBIC ACID | ASCORBIC ACID | PQ6CK8PD0R | TABLET, ORALLY DISINTEGRATING / ORAL | 2.35 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | CREAM / TOPICAL | NA | ||
| CARBOXYMETHYLCELLULOSE CALCIUM | CARBOXYMETHYLCELLULOSE CALCIUM | UTY7PDF93L | TABLET, ORALLY DISINTEGRATING / ORAL | 45 mg | ||
| ASCORBIC ACID | ASCORBIC ACID | PQ6CK8PD0R | INJECTION / INTRAVENOUS | 1440 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | INSERT / VAGINAL | 69 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | SUSPENSION / OPHTHALMIC | 0.5 %w/w | ||
| ASCORBIC ACID | ASCORBIC ACID | PQ6CK8PD0R | SOLUTION / TOPICAL | 0.04 %w/w | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, EXTENDED RELEASE / ORAL | 119.7 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | WAFER / ORAL | 66 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION / INTRAMUSCULAR | 203.5 mg | ||
| ASCORBIC ACID | ASCORBIC ACID | PQ6CK8PD0R | CAPSULE / ORAL | 7 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION / INTRAVENOUS | 203.5 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | LOTION / TOPICAL | 0.1 %w/w | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, EXTENDED RELEASE / ORAL | 400 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | SYSTEM / INTRAVITREAL | 0.02 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | TABLET, ORALLY DISINTEGRATING / ORAL | 41 mg | ||
| ASCORBIC ACID | ASCORBIC ACID | PQ6CK8PD0R | INJECTION, SOLUTION / INFILTRATION | 0.2 %w/v | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 133 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | DROPS / ORAL | NA | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / SUBLINGUAL | 17.5 mg | ||
| ASCORBIC ACID | ASCORBIC ACID | PQ6CK8PD0R | SOLUTION / ORAL | 600 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED / ORAL | 96 mg | ||
| ASCORBIC ACID | ASCORBIC ACID | PQ6CK8PD0R | CAPSULE, DELAYED RELEASE / ORAL | 12 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, SUGAR COATED / ORAL | NA | ||
| CARBOXYMETHYLCELLULOSE CALCIUM | CARBOXYMETHYLCELLULOSE CALCIUM | UTY7PDF93L | TABLET / ORAL | 967 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 133 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / ORAL | 2500 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | POWDER, FOR SUSPENSION / ORAL | 120 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, CHEWABLE / ORAL | 127 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | SUSPENSION / ORAL | 64 mg | ||
| ASCORBIC ACID | ASCORBIC ACID | PQ6CK8PD0R | TABLET, FILM COATED / ORAL | 20 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | SHAMPOO / TOPICAL | 3 %w/w | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | SUSPENSION / ORAL | 305 mg | ||
| HYPROMELLOSES | HYPROMELLOSE | 3NXW29V3WO | CAPSULE, COATED PELLETS / ORAL | 3.32 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET, EXTENDED RELEASE / ORAL | 173 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CONCENTRATE / ORAL | NA |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| a32e5228-31a4-4d90-aabb-40e177bf72fe | 44b31b35-8176-4f5b-bcca-3b7c17eccd98 | 2013-02-26 | Warnings | a32e5228-31a4-4d90-aabb-40e177bf72fe 44b31b35-8176-4f5b-bcca-3b7c17eccd98 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
